A Study In Healthy Subjects Of Single Doses of PF-05230901 Injected Under The Skin

• Status: Terminated
• Trial end date: 2011-09-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will examine whether a single dose of PF-05230901 is safe and well tolerated when given to healthy volunteers by injection under the skin. An additional objective is to measure the blood concentrations of PF-05230901. Each dose will be tested in a different group of subjects starting from the lowest dose.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Pfizer

Criteria

Inclusion Criteria:

• Healthy subjects

Exclusion Criteria:

• History of seizures, including childhood seizures.

• History of movement disorders or related neurological conditions.

• History of head trauma associated with loss of consciousness.